company background image
002773 logo

Chengdu Kanghong Pharmaceutical Group SZSE:002773 Stock Report

Last Price

CN¥19.71

Market Cap

CN¥18.1b

7D

-2.7%

1Y

23.5%

Updated

30 Jul, 2024

Data

Company Financials

Chengdu Kanghong Pharmaceutical Group Co., Ltd

SZSE:002773 Stock Report

Market Cap: CN¥18.1b

002773 Stock Overview

Research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China.

002773 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Chengdu Kanghong Pharmaceutical Group Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chengdu Kanghong Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥19.71
52 Week HighCN¥24.50
52 Week LowCN¥13.15
Beta0.0091
11 Month Change-8.96%
3 Month Change-9.17%
1 Year Change23.50%
33 Year Change3.03%
5 Year Change-39.54%
Change since IPO95.99%

Recent News & Updates

Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Jun 21
Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

May 12
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

Recent updates

Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Jun 21
Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

May 12
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

Lacklustre Performance Is Driving Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Low P/E

Mar 27
Lacklustre Performance Is Driving Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Low P/E

Shareholder Returns

002773CN PharmaceuticalsCN Market
7D-2.7%-5.9%-3.0%
1Y23.5%-17.9%-21.8%

Return vs Industry: 002773 exceeded the CN Pharmaceuticals industry which returned -17.9% over the past year.

Return vs Market: 002773 exceeded the CN Market which returned -21.8% over the past year.

Price Volatility

Is 002773's price volatile compared to industry and market?
002773 volatility
002773 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement5.7%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 002773 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002773's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19964,289Xiao Kewww.cnkh.com

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs.

Chengdu Kanghong Pharmaceutical Group Co., Ltd Fundamentals Summary

How do Chengdu Kanghong Pharmaceutical Group's earnings and revenue compare to its market cap?
002773 fundamental statistics
Market capCN¥18.12b
Earnings (TTM)CN¥1.14b
Revenue (TTM)CN¥4.17b

15.9x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002773 income statement (TTM)
RevenueCN¥4.17b
Cost of RevenueCN¥449.76m
Gross ProfitCN¥3.72b
Other ExpensesCN¥2.58b
EarningsCN¥1.14b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 23, 2024

Earnings per share (EPS)1.24
Gross Margin89.20%
Net Profit Margin27.34%
Debt/Equity Ratio0%

How did 002773 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.